Early research (Phase 1)Study completedNCT03000257What this trial is testingBudigalimab (ABBV-181) in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 182
Testing effectiveness (Phase 2)Study completedNCT00333502What this trial is testingStudy of CRLX101 (NLG207) in the Treatment of Advanced Solid TumorsWho this might be right forCancerSolid Tumor NewLink Genetics Corporation 62
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Study completedNCT05585034What this trial is testingPhase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid TumorsWho this might be right forHead and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more Xencor, Inc. 60
Early research (Phase 1)Ended earlyNCT01212887What this trial is testingTreated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With CancerWho this might be right forBreast CancerColorectal CancerGastric Cancer+4 more Cancer Research UK 14
Not applicableUnknownNCT03517332What this trial is testingCirculating Tumor DNA Exposure in Peripheral BloodWho this might be right forColorectal CancerPancreatic AdenocarcinomaGastric Cancer+8 more Quantgene Inc. 10,000
Testing effectiveness (Phase 2)Study completedNCT00003072What this trial is testingCombination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung CancerWho this might be right forLung CancerNeurotoxicityOvarian Cancer University of California, San Francisco 80
Early research (Phase 1)Study completedNCT02729298What this trial is testingFirst-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsEGFR Positive Non-small Cell Lung CancerColorectal Carcinoma+2 more Sumitomo Pharma America, Inc. 177
Testing effectiveness (Phase 2)Looking for participantsNCT06953089What this trial is testingDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid TumorsWho this might be right forSolid Tumors DualityBio Inc. 492
Not applicableUnknownNCT04066335What this trial is testingStudy to Evaluate the Safety of Nanoxel M Inj.Who this might be right forBreast CancerNon-small Cell Lung CancerProstate Cancer+4 more Samyang Biopharmaceuticals Corporation 1,498
Large-scale testing (Phase 3)Active Not RecruitingNCT03815643What this trial is testingAvelumab Program Rollover StudyWho this might be right forSolid Tumors EMD Serono Research & Development Institute, Inc. 205
Early research (Phase 1)Active Not RecruitingNCT06607185What this trial is testingThe Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsWho this might be right forPancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerColorectal Cancer+2 more Eli Lilly and Company 750
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Not applicableWithdrawnNCT04889495What this trial is testingA Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various CancerWho this might be right forNon-small Cell Lung CancerMetastatic Colorectal CancerMetastatic Breast Cancer+5 more Pfizer
Early research (Phase 1)Study completedNCT03538028What this trial is testingA Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesWho this might be right forCervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more Incyte Biosciences International Sàrl 22
Early research (Phase 1)UnknownNCT03076372What this trial is testingA Study Evaluating MM-310 in Patients With Solid TumorsWho this might be right forSolid TumorsUrothelial CarcinomaGastric Carcinoma+9 more Merrimack Pharmaceuticals 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT03319628What this trial is testingFirst-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2bWho this might be right forPlatinum Resistant Ovarian CancerNon Small Cell Lung Cancer Metastatic Mersana Therapeutics 523
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526What this trial is testingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCWho this might be right forNon Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more OncoC4, Inc. 733
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Post-approval studies (Phase 4)Study completedNCT03384511What this trial is testingThe Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.Who this might be right forMalignanciesStomach CancerNon-small Cell Lung Cancer+4 more Shandong Cancer Hospital and Institute 38